Technology
Health
Biotechnology
Outlook Therapeutics
$2.809876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.83 (42.35%) Today
+$0.01 (0.36%) After Hours
Why Robinhood?
You can buy or sell OTLK and other stocks, options, ETFs, and crypto commission-free!
About
Outlook Therapeutics, Inc. Common Stock, also called Outlook Therapeutics, is a clinical-stage biopharmaceutical company. Read More The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.
Employees
56
Headquarters
Cranbury, New Jersey
Founded
2010
Market Cap
20.85M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.00M
High Today
$2.89
Low Today
$2.23
Open Price
$2.39
Volume
11.14M
52 Week High
$10.96
52 Week Low
$0.85
Collections
Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Pharmaceutical
2016 IPO
Price Paid on Robinhood
7% Higher
Right Now
52 Week Low
$0.85
Average Price Paid
$2.63
52 Week High
$10.96
Earnings
-$0.70
-$0.62
-$0.54
-$0.46
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
-$0.58 per share